Review: taking Mobic and Celebrex together


Summary

Drug interactions are reported among people who take Mobic and Celebrex together. This review analyzes the effectiveness and drug interactions between Mobic and Celebrex. It is created by eHealthMe based on reports of 990 people who take the same drugs from FDA and social media, and is updated regularly.

You are not alone

Join a support group for people who take Mobic and Celebrex >>>

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA and social media since 1977. Our tools are free and anonymous. 86 million people have used us. 300+ peer-reviewed medical journals have referenced our original studies. Start now >>>


Mobic

Mobic has active ingredients of meloxicam. It is often used in rheumatoid arthritis. (latest outcomes from Mobic 13,811 users)

Celebrex

Celebrex has active ingredients of celecoxib. It is often used in arthritis. (latest outcomes from Celebrex 80,958 users)

On Aug, 22, 2016

990 people who take Mobic, Celebrex are studied.


Number of reports submitted per year:

Mobic and Celebrex drug interactions.

Drug effectiveness over time:

Mobic:
  • < 1 month: 0.0% - (0 of 2 people)
  • 1 - 6 months: 0.0% - (0 of 3 people)
  • 6 - 12 months: 0.0% - (0 of 1 people)
  • 1 - 2 years: 0.0% - (0 of 2 people)
  • 2 - 5 years: 0.0% - (0 of 0 people)
  • 5 - 10 years: 0.0% - (0 of 1 people)
  • 10+ years: 0.0% - (0 of 0 people)
  • not specified: 0.0% - (0 of 0 people)
Celebrex:
  • < 1 month: 0.0% - (0 of 2 people)
  • 1 - 6 months: 33.0% - (1 of 3 people)
  • 6 - 12 months: 0.0% - (0 of 1 people)
  • 1 - 2 years: 0.0% - (0 of 0 people)
  • 2 - 5 years: 0.0% - (0 of 1 people)
  • 5 - 10 years: 100.0% - (4 of 4 people)
  • 10+ years: 0.0% - (0 of 0 people)
  • not specified: 0.0% - (0 of 0 people)

Drug effectiveness by gender:

Mobic:
  • female: 0.0% - (0 of 5 people)
  • male: 0.0% - (0 of 4 people)
Celebrex:
  • female: 60.0% - (3 of 5 people)
  • male: 33.0% - (2 of 6 people)

Drug effectiveness by age:

Mobic:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 0.0% - (0 of 0 people)
  • 30-39: 0.0% - (0 of 2 people)
  • 40-49: 0.0% - (0 of 1 people)
  • 50-59: 0.0% - (0 of 3 people)
  • 60+: 0.0% - (0 of 3 people)
Celebrex:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 0.0% - (0 of 1 people)
  • 30-39: 50.0% - (1 of 2 people)
  • 40-49: 0.0% - (0 of 1 people)
  • 50-59: 50.0% - (2 of 4 people)
  • 60+: 66.0% - (2 of 3 people)

Most common drug interactions over time *:

< 1 month:
  • pain
  • drug ineffective
  • nausea
  • vomiting
  • weight decreased
  • abdominal distension
  • decreased appetite
  • knee arthroplasty
  • dizziness
  • insomnia
1 - 6 months:
  • myocardial infarction
  • anaemia
  • chest pain
  • abdominal pain upper
  • back pain
  • pain in extremity
  • sleep apnoea syndrome
  • arthropathy
  • depression
  • diverticulitis
6 - 12 months:
  • pain in extremity
  • musculoskeletal discomfort
  • pain
  • blood cholesterol increased
  • bursitis
  • limb discomfort
  • renal impairment
  • musculoskeletal stiffness
  • myalgia
  • constipation
1 - 2 years:
  • cerebrovascular accident
  • stress
  • abdominal pain upper
  • anxiety
  • arthritis
  • knee arthroplasty
  • pain
  • adverse event
  • angiopathy
  • arthralgia
2 - 5 years:
  • hypertension
  • back pain
  • pain in extremity
  • coronary artery disease
  • abdominal pain upper
  • cardiomegaly
  • drug ineffective
  • myocardial infarction
  • anaemia
  • arthropathy
5 - 10 years:
  • feeling hot
  • gastrointestinal pain
  • hypoaesthesia
  • incisional hernia
  • livedo reticularis
  • lupus-like syndrome
  • osteoporosis
  • coronary artery disease
  • arthropathy
  • cyst
10+ years:
  • abdominal pain upper
  • arthritis
  • cardiac disorder
  • drug administration error
  • gastric disorder
  • myocardial infarction
  • rectal haemorrhage
not specified:
  • pain
  • anxiety
  • arthralgia
  • pain in extremity
  • anaemia
  • bone disorder
  • osteoarthritis
  • osteonecrosis of jaw
  • back pain
  • fatigue

Most common drug interactions by gender *:

female:
  • pain
  • anxiety
  • pain in extremity
  • arthralgia
  • anaemia
  • back pain
  • osteoarthritis
  • fall
  • bone disorder
  • osteonecrosis of jaw
male:
  • pain
  • depression
  • gastrooesophageal reflux disease
  • bone disorder
  • arthralgia
  • anaemia
  • paraesthesia
  • dyspnoea
  • fatigue
  • hypoaesthesia

Most common drug interactions by age *:

0-1:
  • blood cholesterol increased
  • gallbladder operation
  • sensation of foreign body
  • type 2 diabetes mellitus
2-9:
  • febrile neutropenia
  • rash
  • white blood cell count decreased
  • meningitis viral
  • rocky mountain spotted fever
10-19:
  • anaphylactic shock
  • arthralgia
  • back pain
  • bladder prolapse
  • chest pain
  • cushing's syndrome
  • drug ineffective
  • dysuria
  • erythema
  • gastrointestinal disorder
20-29:
  • anxiety
  • diarrhoea
  • vomiting
  • abdominal pain
  • biliary dyskinesia
  • convulsion
  • deep vein thrombosis
  • depression
  • gallbladder non-functioning
  • mental disorder
30-39:
  • arthritis
  • back pain
  • abdominal pain upper
  • dizziness
  • cholelithiasis
  • bronchitis
  • resorption bone increased
  • glaucoma
  • nausea
  • neuropathy peripheral
40-49:
  • pain
  • anxiety
  • back pain
  • injury
  • pain in extremity
  • anhedonia
  • bone disorder
  • fall
  • pulmonary embolism
  • arthralgia
50-59:
  • pain
  • anxiety
  • emotional distress
  • oedema peripheral
  • bone disorder
  • constipation
  • arthralgia
  • spinal osteoarthritis
  • tooth loss
  • pyrexia
60+:
  • anaemia
  • pain in extremity
  • pain
  • osteonecrosis of jaw
  • osteoarthritis
  • arthralgia
  • bone disorder
  • fatigue
  • back pain
  • dyspnoea

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you take Mobic and Celebrex?

Can you answer these questions?

More questions for: Mobic, Celebrex

You may be interested in these reviews

More reviews for: Mobic, Celebrex

On eHealthMe, Mobic (meloxicam) is often used to treat rheumatoid arthritis. Celebrex (celecoxib) is often used to treat arthritis. Find out below the conditions the drugs are used for and how effective they are.

What is the drug used for and how effecitve is it:


NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.